Sleep Apnea
-
CES 2025
APNEAL Unveils the World’s First AI-Powered App to Detect Sleep Apnea Using Just a Smartphone
At CES 2025, deeptech startup APNEAL unveils the first-ever medical device technology that enables advanced sleep examinations at home using nothing more than a smartphone. This AI-powered app transforms ordinary smartphones into accessible diagnostic tools, eliminating the need for sleep clinics or complex equipment for most patients. With nearly 80% of sleep apnea cases undiagnosed, APNEAL offers a simple, affordable,…
Read More » -
Press Releases
RingConn Showcases Gen 2 Smart Ring at IFA 2024: Revolutionizing Sleep Monitoring with Integrated Sleep Apnea Detection
RingConn, a leading personal health technology company, recently showcased its newest innovation—the RingConn Gen 2 Smart Ring—at IFA 2024. This groundbreaking device is the first smart ring to feature integrated sleep apnea monitoring*, redefining smart wearable device. RingConn Gen 2 Smart Ring was initially launched on the Kickstarter crowdfunding platform on August 1, where it has already raised almost $4 million from around…
Read More » -
Press Releases
Apple introduces groundbreaking health features to support conditions impacting billions of people
Apple today unveiled breakthrough sleep and hearing health features coming to Apple Watch and AirPods Pro 2 that further deliver on Apple’s commitment to health with experiences that enrich users’ lives. These new features expand across products, bringing informative and powerful ways to support users in their sleep and hearing health for conditions that impact billions globally. Using an innovative new Breathing Disturbances metric,…
Read More » -
Press Releases
Samsung’s Sleep Apnea Feature on Galaxy Watch First of Its Kind Authorized by US FDA
Samsung Electronics Co., Ltd. announced that the sleep apnea feature1 on the Samsung Health Monitor app2 has received De Novo authorization from the United States Food and Drug Administration (FDA). This feature, will detect signs of sleep apnea using a compatible Samsung Galaxy Watch and Phone, is the first of its kind to be authorized by FDA following previous approval by South Korea’s Ministry of Food and Drug…
Read More » -
Press Releases
BodiMetrics’ Prevention circul+ Ring Sleep Apnea Detection Comparable to Sleep Lab Tests
BodiMetrics announced today the results of a 164 patient clinical study that compared their Prevention circul+ wearable ring device versus traditional polysomnography (PSG) test. The results revealed that the circul+ compares favorably to the conventional and bulkier PSG systems widely used for sleep apnea detection. Prevention circul+ sleep apnea results comparable to lab sleep study The Prevention circul+ measure heart rate,…
Read More » -
Respicardia Announces Highmark Coverage for the remedē® System in Patients with Central Sleep Apnea
MINNETONKA, Minn., Jan. 7, 2021 /PRNewswire/ — Respicardia, Inc., the manufacturer of the only FDA-approved active implantable system for the treatment of central sleep apnea (CSA), announced today that Highmark Blue Cross Blue Shield and its affiliates will provide coverage for the Company’s remedē® System therapy, effective immediately. Highmark provides health insurance coverage to over 5 million individuals across Pennsylvania, Delaware and West Virginia. The remedē® System “We are…
Read More » -
Press Releases
World’s First Self-Learning Snore Mask Launches on Indiegogo
Hüpnos announces the launch of their Indiegogo campaign, bringing the world’s first self-learning snore-reduction mask to the public. It is estimated that 90 million Americans suffer from persistent snoring, leading to a poorer quality of sleep for themselves and their partner. The resulting daytime fatigue causes extreme difficulty with concentration, focus and memory. It’s not surprising the Centers for Disease Control and Prevention…
Read More » -
Press Releases
ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers
SAN DIEGO & SOUTH SAN FRANCISCO–(BUSINESS WIRE)–ResMed (NYSE: RMD, ASX: RMD), a global leader in sleep apnea treatment and connected health solutions, and Verily, an Alphabet company, today announced their agreement to form a new joint venture. .@ResMed and Verily to form joint venture to help reach millions of untreated #SleepApnea sufferers Tweet this Combining ResMed’s expertise in sleep apnea…
Read More »